• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

医学领域技术变革的动态

The dynamics of technological change in medicine.

作者信息

Gelijns A, Rosenberg N

出版信息

Health Aff (Millwood). 1994 Summer;13(3):28-46. doi: 10.1377/hlthaff.13.3.28.

DOI:10.1377/hlthaff.13.3.28
PMID:7927160
Abstract

This paper contrasts a dynamic and interactive view of technological change with the linear model of medical innovation that is still so deeply ingrained in many policy discussions. In particular, it focuses on the role of feedback mechanisms between the users and the developers of medical technology and the demand and supply forces (including competition among medical specialties) determining this feedback. It explores three distinct mechanisms by which technological change may contribute to rising health care spending: intensity of use of existing technology, introduction of new technologies, and expanded application of these new technologies.

摘要

本文将技术变革的动态交互观点与医学创新的线性模型进行了对比,后者在许多政策讨论中仍然根深蒂固。具体而言,它聚焦于医疗技术使用者与开发者之间反馈机制的作用,以及决定这种反馈的供需力量(包括医学专科之间的竞争)。它探讨了技术变革可能导致医疗保健支出增加的三种不同机制:现有技术的使用强度、新技术的引入以及这些新技术的扩展应用。

相似文献

1
The dynamics of technological change in medicine.医学领域技术变革的动态
Health Aff (Millwood). 1994 Summer;13(3):28-46. doi: 10.1377/hlthaff.13.3.28.
2
Innovation under federal health care reform.联邦医疗保健改革下的创新。
Health Aff (Millwood). 1994 Summer;13(3):82-97. doi: 10.1377/hlthaff.13.3.82.
3
Medical innovation duels cost containment.医学创新与成本控制相互较量。
Health Aff (Millwood). 1994 Summer;13(3):7-27. doi: 10.1377/hlthaff.13.3.7.
4
Financing the correct rate of growth of medical technology.为医疗技术的合理增长率提供资金支持。
Q Rev Econ Bus. 1990 Winter;30(4):54-60.
5
Healthcare costs for new technologies.
Eur J Nucl Med Mol Imaging. 2009 Mar;36 Suppl 1:S139-43. doi: 10.1007/s00259-008-0975-y.
6
Improving the use of medical technology.
Health Aff (Millwood). 1982 Spring;1(2):86-102. doi: 10.1377/hlthaff.1.2.86.
7
Competition in health care.
Ophthalmology. 2002 Sep;109(9):1583. doi: 10.1016/s0161-6420(02)01191-0.
8
A changing paradigm in the study and adoption of emerging health care technologies: coverage with evidence development.新兴医疗技术研究与应用中的范式转变:基于证据生成的覆盖范围
J Am Coll Radiol. 2008 Nov;5(11):1125-9. doi: 10.1016/j.jacr.2008.06.008.
9
Preserving the milieu for medical innovation.
Health Aff (Millwood). 1994 Summer;13(3):112-4. doi: 10.1377/hlthaff.13.3.112.
10
The new NICE Evaluation Pathway for medical technologies.英国国家卫生与临床优化研究所(NICE)新的医疗技术评估途径。
Ann R Coll Surg Engl. 2010 Jul;92(5):435-6.

引用本文的文献

1
Ensuring safety and efficacy in combination products: regulatory challenges and best practices.确保组合产品的安全性和有效性:监管挑战与最佳实践。
Front Med Technol. 2024 Jul 10;6:1377443. doi: 10.3389/fmedt.2024.1377443. eCollection 2024.
2
Accelerated innovation in crises: The role of collaboration in the development of alternative ventilators during the COVID-19 pandemic.危机中的加速创新:合作在新冠疫情期间替代呼吸机研发中的作用。
Technol Soc. 2022 Feb;68:101923. doi: 10.1016/j.techsoc.2022.101923. Epub 2022 Feb 9.
3
Medical Device Product Innovation Choices in Asia: An Empirical Analysis Based on Product Space.
亚洲医疗器械产品创新选择:基于产品空间的实证分析
Front Public Health. 2022 Apr 13;10:871575. doi: 10.3389/fpubh.2022.871575. eCollection 2022.
4
Variety patterns in defense and health technological systems: evidence from international trade data.国防与健康技术系统中的多样化模式:来自国际贸易数据的证据
J Evol Econ. 2020;30(4):949-988. doi: 10.1007/s00191-020-00700-9. Epub 2020 Sep 11.
5
R&D in Vaccines Targeting Neglected Diseases: An Exploratory Case Study Considering Funding for Preventive Tuberculosis Vaccine Development from 2007 to 2014.针对被忽视疾病的疫苗研发:一项探索性案例研究,考量2007年至2014年预防性结核病疫苗研发的资金情况
Biomed Res Int. 2017;2017:4765719. doi: 10.1155/2017/4765719. Epub 2017 Jan 4.
6
For-profit hospital ownership status and use of brachytherapy after breast-conserving surgery.营利性医院所有权状况与保乳手术后近距离放射治疗的使用情况
Surgery. 2014 May;155(5):776-88. doi: 10.1016/j.surg.2013.12.009. Epub 2013 Dec 15.
7
The sustainability of European health care systems: beyond income and aging.欧洲医疗保健系统的可持续性:超越收入和老龄化。
Eur J Health Econ. 2012 Oct;13(5):623-34. doi: 10.1007/s10198-011-0337-8. Epub 2011 Aug 4.
8
Medicare's policy on carotid stents limited use to hospitals meeting quality guidelines yet did not hurt disadvantaged.医疗保险政策规定颈动脉支架的使用仅限于符合质量标准的医院,但这并没有对弱势群体造成伤害。
Health Aff (Millwood). 2011 Feb;30(2):312-21. doi: 10.1377/hlthaff.2010.0320.
9
The "biosecuritization" of healthcare delivery: examples of post-9/11 technological imperatives.医疗服务的“生物安保化”:9·11 后技术必要性的实例。
Soc Sci Med. 2011 Feb;72(4):545-52. doi: 10.1016/j.socscimed.2010.11.017. Epub 2010 Nov 27.
10
Comparative effectiveness, personalized medicine and innovation: the path forward.比较效果、个性化医疗与创新:前进之路。
Pharmacoeconomics. 2010;28(10):923-30. doi: 10.2165/11539030-000000000-0000010.2165/11537370-000000000-00000.